These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 18679556
21. Adrenal function as assessed by low-dose adrenocorticotropin hormone test before and after switching from inhaled beclomethasone dipropionate to inhaled fluticasone propionate. Niitsuma T, Okita M, Sakurai K, Morita S, Tsuyuguchi M, Matsumura Y, Hayashi T, Koshishi T, Oka K, Homma M. J Asthma; 2003; 40(5):515-22. PubMed ID: 14529101 [Abstract] [Full Text] [Related]
22. Fluticasone propionate/salmeterol and exercise-induced asthma in children with persistent asthma. Pearlman D, Qaqundah P, Matz J, Yancey SW, Stempel DA, Ortega HG. Pediatr Pulmonol; 2009 May; 44(5):429-35. PubMed ID: 19382218 [Abstract] [Full Text] [Related]
23. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma. Peden DB, Berger WE, Noonan MJ, Thomas MR, Hendricks VL, Hamedani AG, Mahajan P, House KW. J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845 [Abstract] [Full Text] [Related]
24. [Adrenal cortex function in children with bronchial asthma in fluticasone therapy]. Hoffmann-Streb A, L'Allemand D, Niggemann B, Büttner P, Wahn U. Monatsschr Kinderheilkd; 1993 Jun; 141(6):508-12. PubMed ID: 8336748 [Abstract] [Full Text] [Related]
25. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients. Derom E, Van De Velde V, Marissens S, Engelstätter R, Vincken W, Pauwels R. Pulm Pharmacol Ther; 2005 Jun; 18(5):328-36. PubMed ID: 15939311 [Abstract] [Full Text] [Related]
26. Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate. Weiner P, Berar-Yanay N, Davidovich A, Magadle R. Chest; 1999 Oct; 116(4):931-4. PubMed ID: 10531155 [Abstract] [Full Text] [Related]
27. Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthma. Kupryś-Lipińska I, Tworek D, Vanderbist F, Bocheńska-Marciniak M, Kuna P. Pneumonol Alergol Pol; 2013 Oct; 81(6):527-36. PubMed ID: 24142782 [Abstract] [Full Text] [Related]
28. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects. Harrison TW, Wisniewski A, Honour J, Tattersfield AE. Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010 [Abstract] [Full Text] [Related]
29. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma. Markham A, Jarvis B. Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128 [Abstract] [Full Text] [Related]
30. Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial. Kemp JP, Osur S, Shrewsbury SB, Herje NE, Duke SP, Harding SM, Faulkner K, Crim CC. Mayo Clin Proc; 2004 Apr; 79(4):458-66. PubMed ID: 15065610 [Abstract] [Full Text] [Related]
31. Systemic exposure and urinary cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4- to 11-year-olds with asthma. Kim KT, Milgrom H, Yoon YK, Levy AL, Matz P, Welch MJ, Cahn A, Collins DA, Kathman S, Mehta R, Su SF, Kunka RL. J Clin Pharmacol; 2008 Jan; 48(1):108-16. PubMed ID: 18094223 [Abstract] [Full Text] [Related]
32. Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects. Harrison TW, Tattersfield AE. Thorax; 2003 Mar; 58(3):258-60. PubMed ID: 12612308 [Abstract] [Full Text] [Related]
33. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T. Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216 [Abstract] [Full Text] [Related]
34. Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers. Wilson AM, Clark DJ, McFarlane L, Lipworth BJ. Eur J Clin Pharmacol; 1997 Mar; 53(1):33-7. PubMed ID: 9349927 [Abstract] [Full Text] [Related]
35. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Clark DJ, Grove A, Cargill RI, Lipworth BJ. Thorax; 1996 Mar; 51(3):262-6. PubMed ID: 8779128 [Abstract] [Full Text] [Related]
36. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study. Brutsche MH, Brutsche IC, Munawar M, Langley SJ, Masterson CM, Daley-Yates PT, Brown R, Custovic A, Woodcock A. Lancet; 2000 Aug 12; 356(9229):556-61. PubMed ID: 10950233 [Abstract] [Full Text] [Related]
37. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children. Lipworth BJ, Clark DJ, McFarlane LC. Thorax; 1997 Aug 12; 52(8):686-9. PubMed ID: 9337826 [Abstract] [Full Text] [Related]
38. Long-term safety and efficacy of fluticasone/formoterol combination therapy in asthma. Mansur AH, Kaiser K. J Aerosol Med Pulm Drug Deliv; 2013 Aug 12; 26(4):190-9. PubMed ID: 23098325 [Abstract] [Full Text] [Related]
39. Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children. Volovitz B, Bilavsky E, Nussinovitch M. J Asthma; 2008 Sep 12; 45(7):561-7. PubMed ID: 18773327 [Abstract] [Full Text] [Related]
40. Inhaled fluticasone at different doses for chronic asthma. Adams N, Bestall JM, Jones PW. Cochrane Database Syst Rev; 2002 Sep 12; (1):CD003534. PubMed ID: 11869675 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]